Fast-Acting Sub-Perception Therapy Spinal Cord Stimulation Reduces Back Pain

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Dec. 6, 2024 -- Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SCS) systems may achieve significant and durable pain relief for up to 12 months of follow-up, according to a study presented at the 23rd Annual Pain Medicine Meeting, a meeting of the American Society of Regional Anesthesia and Pain Medicine, held from Nov. 21 to 23 in Las Vegas.

Magdalena Anitescu, M.D., Ph.D., from the University of Chicago, and colleagues evaluated the effectiveness of FAST and additional SCS therapy options for chronic pain. The analysis included 12-month follow-up data for patients implanted with SCS systems (WaveWriter Systems) for chronic pain.

The researchers found that the primary end point of a ≥50 percent reduction in targeted pain with no increase in average daily opioid medications at three months was achieved by 16 of 20 patients. Treatment responder rates of 81, 84, and 90 percent were achieved at three (52 patients), six (38 patients), and 12 months (30 patients) of follow-up. At a mean onset duration of 2.6 minutes, ≥50 percent pain relief was achieved. A mean 5-point reduction in the verbal rating scale low back pain score was achieved at 12 months. An additional 28-point mean improvement in the Oswestry Disability Index score at 12 months was seen. At all time points, consistently high levels of patient satisfaction were observed (>84 percent reporting much or very much improved).

"These outcomes are consistent with real-world observational studies in the United States of America and European Union," the authors write.

Several authors disclosed ties to Boston Scientific.

Abstract

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-07 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords